電気生理学診断カテーテル市場：市場規模（セグメント別）、シェア、規制、償還、手技、予測（～2033年）

電気生理学的手技は多種多様な不整脈に適用でき、成功率が極めて高く、合併症や再発率が低いです。

不整脈とは、心臓の拍動が速すぎたり遅すぎたり、あるいは不規則なリズムを刻む状態のことです。心拍が速すぎる場合は頻脈と呼ばれます。不整脈は治療しなければ生命を脅かすことがあります。心房細動（AFibまたはAFとも呼ばれる）は、血栓、脳卒中、心不全、その他の心臓関連の合併症を引き起こす不整脈です。

当レポートは、世界の電気生理学診断カテーテル市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている電気生理学診断カテーテルと競合情勢

• 主要な業界動向の洞察
• 電気生理学診断カテーテルのセグメント別総市場収益と2015年～2033年の市場展望
• セグメント別の手技総数、個数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 電気生理学診断カテーテル市場のSWOT分析
• 電気生理学診断カテーテル市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Electrophysiology Diagnostic Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Electrophysiology Diagnostic Catheters market for the year 2020 and beyond. Electrophysiology procedure is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence.

Arrhythmia is a condition of the heart in which the heart is either beating too fast, too slow or with an irregular rhythm. The condition is known as tachycardia when the heartbeat is too fast. Arrhythmias can be life threatening if untreated. Atrial fibrillation (also called AFib or AF) is an irregular heartbeat that lead to blood clots, stroke, heart failure and other heart-related complications.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Electrophysiology Diagnostic Catheters and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Electrophysiology Diagnostic Catheters market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Electrophysiology Diagnostic Catheters market.
• Competitive dynamics insights and trends provided for Electrophysiology Diagnostic Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Johnson & Johnson, Abbott Laboratories Medtronic Plc, Siemens AG, Boston Scientific Corp, Biotronik AG, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Electrophysiology Diagnostic Catheters marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Electrophysiology Diagnostic Catheters market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Electrophysiology Diagnostic Catheters market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Electrophysiology Diagnostic Catheters market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Electrophysiology Diagnostic Catheters market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable